Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, ...
Jul 21, 2015
0
6
Treating people with type 2 diabetes, also known as 'age-related diabetes' with antidiabetics reduces their risk for Alzheimer's and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. ...
Jun 23, 2015
0
49
Results revealed today at The International Liver Congress 2015 show that vitamin E (d-alpha-tocopherol) is an effective treatment for non-alcoholic steatohepatitis (NASH). NASH occurs when the liver becomes inflamed due ...
Apr 23, 2015
0
3
Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National ...
Feb 11, 2015
0
6
Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. However a new study − including more than one million people in six populations worldwide − has found no link between either pioglitazone ...
Dec 3, 2014
0
1
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Jan 26, 2013
1
3
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year ...
Jun 11, 2012
0
0
a drug used to treat type 2 diabetes - is associated with an increased risk of bladder cancer, finds a study published on BMJ today.
May 31, 2012
0
0
(HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology.
Apr 27, 2012
0
0
Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated ...
Jun 16, 2011
0
0
